Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

GSK's triple COPD therapy tops Symbicort in phase III trial

GSK's triple COPD therapy tops Symbicort in phase III trial GlaxoSmithKline has continued to build the case for its three-drug combination for chronic obstructive pulmonary disease, saying it outperformed AstraZeneca's Symbicort in a head-to-head study. ... The phase III FULFIL trial compared the once-daily

AstraZeneca sets sights on China with Takeda deal

AstraZeneca sets sights on China with Takeda deal AZ's respiratory franchise is currently headed by asthma and chronic obstructive pulmonary disease (COPD) drug Symbicort (budesonide and formoterol), which made $2.5bn in the first nine months of the

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in 2014. . Sales were $6.7bn for the year - a fall of 20% as pricing pressures and competition from products such as AstraZeneca's Symbicort affected its once dominant market share.

Prescribing costs jump in England

Prescribing costs jump in England After Seretide, another respiratory drug from AstraZeneca - Symbicort - saw the second highest spend with £89m, while Novo Nordisk's insulin NovoRapid came in third with the NHS spending £75m on the

AstraZeneca and EHR firm to use drug alert system

AstraZeneca and EHR firm to use drug alert system AZ currently markets a number of blockbuster medicines for respiratory disorders, including its new treatment Duaklir Genuair, as well as Pulmicort and Symbicort.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...